The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy

View/Open
Brown_et_al_BCLAF1_and_rectal_cancer_final_manuscript_with_figures.pdf (1.332Mb)
Publication date
03/2016
Author
Metadata
Show full item record
Citation
Brown , G T , Cash , B , Alnabulsi , A , Samuel , L M & Murray , G I 2016 , ' The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy ' , Histopathology , vol. 68 , no. 4 , pp. 556-566 . https://doi.org/10.1111/his.12780
URI
http://hdl.handle.net/2164/8258
DOI
https://doi.org/10.1111/his.12780
Rights
This is the peer reviewed version of the following article:Brown G T, Cash B, Alnabulsi A, Samuel L M & Murray G I (2016) Histopathology 68, 556–566. The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy, which has been published in final form at DOI: 10.1111/his.12780. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Collections